Riskpilot← Back to searchSign inGet full accessASSENS LÆGEHUS ApS
APSActiveCVR 26673364Skelvænget 2Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2002— employees
Revenue 2024
DKK 777K
-1% vs 2023
EBITDA margin
72.7%
+6% vs 2023
Equity ratio
45.8%
Financial strength
Net profit 2024
DKK 321K
+9% vs 2023
| Revenue | DKK 777K | -1% |
| EBITDA | DKK 565K | +6% |
| Net profit | DKK 321K | +9% |
| Total assets | DKK 8,7M | -3% |
| Equity | DKK 4M | +3% |
| Employees | — | — |
Legal name
ASSENS LÆGEHUS ApS
CVR number
26673364
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
1. juli 2002
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at eje og udleje ejendommen, matr.nr. 65 L Assens Markjorder
Address
Skelvænget 2
Email
assens.laegehus@dadlnet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 748 | 808 | 800 | 786 | 777 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -202 | 1.060 | 609 | 533 | 565 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -202 | 1.060 | 609 | 533 | 565 |
| Net financials | -183 | -94 | -122 | -156 | -153 |
| Profit before tax | -385 | 966 | 487 | 377 | 412 |
| Tax | -84 | 213 | 108 | 83 | 91 |
| Net profit | -301 | 753 | 379 | 294 | 321 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8.984 | 9.367 | 9.120 | 8.875 | 8.651 |
| Equity | 3.013 | 3.565 | 3.744 | 3.838 | 3.959 |
| Long-term debt | 3.716 | 3.527 | 3.337 | 3.147 | 2.954 |
| Short-term debt | 1.962 | 1.922 | 1.724 | 1.628 | 1.519 |
| Total debt | 5.678 | 5.449 | 5.061 | 4.775 | 4.473 |
EBITDA margin
72.7%
This company
15.8%
Market median
+360% vs market
20202024
Equity ratio
45.8%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20202024
Net profit margin
41.3%
This company
8.1%
Market median
+410% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
KD Founder | Founder | 2002 |
MS Founder | Founder | 2002 |
LM Founder | Founder | 2002 |
OS Founder | Founder | 2002 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25–33.32% | 25–33.32% | 2025 | |
| Individual | 25–33.32% | 25–33.32% | 2024 | |
| Individual | 25–33.32% | 25–33.32% | 2024 | |
| Individual | 25–33.32% | 25–33.32% | 2024 | |
| Individual | 20–24.99% | 20–24.99% | 2014 | |
| Individual | 20–24.99% | 20–24.99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASSENS LÆGEHUS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsten Dahl Andersen | Founder | 0 companies |
| Magne Sætre | Founder | 0 companies |
| Lena Maria Falk Sele | Founder | 0 companies |
| Otto Sørensen | Founder | 0 companies |